No Data
No Data
No Data
No Data
No Data
Doximity's Strong Market Position Amidst Economic Headwinds: A Balanced Hold Recommendation
TipRanks19:06
Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market
BusinesswireApr 26 04:01
Doximity Raised to Neutral From Underweight by JP Morgan
Doximity Raised to Neutral From Underweight by JP Morgan
Dow JonesApr 25 20:57
Doximity Price Target Announced at $25.00/Share by JP Morgan
Doximity Price Target Announced at $25.00/Share by JP Morgan
Dow JonesApr 25 20:57
Komo: Upgraded the DOCS.US (DOCS.US) rating from reduced holdings to a neutral rating, with a target price of $25.00.
Komo: Upgraded the DOCS.US (DOCS.US) rating from reduced holdings to a neutral rating, with a target price of $25.00.
Zhitong FinanceApr 25 20:50
JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target Is $25
JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25.
MT NewswiresApr 25 19:08
No Data
No Data